{"preliminary_commentary":{"by_channel":{"x_thread":5,"youtube":2,"podcast":1},"note":"Preliminary. Indexed podcasts, YouTube videos and posts on X and Bluesky that name this trial so far. LinkedIn posts are read for reports and the Enterprise MCP, not yet for this index. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this."},"free_build":{"available":true,"how":"POST https://www.erudio.com/api/trial-requests with {\"nct_id\": \"NCT06742996\", \"email\": \"<work email>\"}. The person who owns that inbox must confirm by the emailed link; agents cannot confirm. The result is the report's free public preview; the full report is still bought."},"commentary_summary":{"generated_at":"2026-11-20T02:50:55.032Z","note":"Automated from all 8 indexed sources (Jun 2025 – Oct 2026). Each question is raised in at least two. Not an Erudio report: no source links. Not medical advice.","passages_read":8,"text":"- Whether sonrotoclax with an anti-CD20 antibody improves on venetoclax-rituximab in relapsed CLL\n- Whether obinutuzumab or rituximab is the more suitable antibody partner for sonrotoclax in relapsed CLL\n- Whether stopping sonrotoclax in MRD-negative patients after induction can replace continued fixed-duration treatment","kind":"questions"},"drugs_tested":[["sonrotoclax","zanubrutinib"]],"indication":"relapsed/refractory mantle cell lymphoma","name":"CELESTIAL-RRMCL","nct_id":"NCT06742996","offer":{"currency":"USD","how":"Buy the first edition with create_order on https://mcp.erudio.com/mcp (product \"first_edition\", report \"NCT06742996\", the buyer's work email and organization), or POST https://www.erudio.com/api/orders with the same fields. It returns a Stripe checkout_url for your person to pay by card; a first edition has no agent-wallet payment. The person can also order on https://www.erudio.com/trials/celestial-rrmcl-nct06742996. We build the first edition within 24 hours of payment and email it to you once it passes our checks and review. If your report can't be delivered, we'll contact you and refund it in full.","price_rule":"Never more than quoted: the buyer pays the smaller of price_usd and the price the delivered edition is sold at.","price_usd":750,"product":"first_edition","size":"focused","size_rule":"Focused: 1–150 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":null,"arms":[{"description":"Sonrotoclax and zanubrutinib will be administered in combination.","label":"Arm A: sonrotoclax plus zanubrutinib","type":"EXPERIMENTAL"},{"description":"Placebo and zanubrutinib will be administered in combination.","label":"Arm B: placebo plus zanubrutinib","type":"PLACEBO_COMPARATOR"}],"collaborators":[],"completion_date":{"date":"2032-03-30","type":"ESTIMATED"},"conditions":["Mantle Cell Lymphoma","B Cell Lymphoma"],"enrollment":{"count":300,"type":"ESTIMATED"},"has_results":false,"interventions":[{"name":"Sonrotoclax","otherNames":["BGB-11417"],"type":"DRUG"},{"name":"Zanubrutinib","otherNames":["Brukinsa","BGB-3111"],"type":"DRUG"},{"name":"Placebo","otherNames":[],"type":"DRUG"}],"last_update":"2026-10-29","lead_sponsor":"BeOne Medicines","official_title":"A Phase 3 Randomized Double-Blind Multicenter Study of Sonrotoclax Plus Zanubrutinib Versus Placebo Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma","overall_status":"RECRUITING","phases":["PHASE3"],"primary_completion_date":{"date":"2028-08-31","type":"ESTIMATED"},"primary_outcomes":[{"measure":"Progression-Free Survival (PFS) as assessed by Blinded Independent Review Committee (BIRC)","timeFrame":"Approximately 41 months"}],"references":[],"start_date":{"date":"2025-03-05","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)","url":"https://clinicaltrials.gov/study/NCT06742996"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.3","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/celestial-rrmcl-nct06742996"}